Insurer WellPoint's 3Q net income edges higher

(AP)—WellPoint says its third-quarter net income rose 1 percent, as the nation's second largest health insurer trimmed expenses to balance flat revenue and an enrollment decline.

The Indianapolis-based company says it earned $691.2 million, or $2.15 per share, in the three months that ended Sept. 30. That's up from $683.2 million, or $1.90 per share, in last year's third quarter.

Excluding investment gains, adjusted earnings were $2.09 per share. Analysts expected $1.83 per share.

Its revenue excluding investments was $15.13 billion. Analysts expected $15.3 billion in revenue.

says its enrollment fell more than 2 percent to about 33.5 million people compared to last year.

The company operates Blue Cross Blue Shield plans in 14 states, including California, New York and Ohio.

not rated yet
add to favorites email to friend print save as pdf

Related Stories

CenturyLink 3Q net income falls as expenses rise

Nov 02, 2011

(AP) -- Phone company CenturyLink Inc. says its third-quarter net income fell as rising operating expenses related to its April acquisition of larger phone company Qwest overshadowed increased revenue.

Qualcomm 3Q results beat Wall Street estimates

Jul 20, 2011

(AP) -- Wireless chip-maker Qualcomm Inc.'s results for the latest quarter beat Wall Street's expectations, and its projections for the current quarter are also above analysts' estimates.

Recommended for you

Cambodia bans 'virgin surgery' adverts

7 hours ago

The Cambodian government has ordered a hospital to stop advertising so-called virginity restoration procedures, saying it harms the "morality" of society.

What's happening with your donated specimen?

22 hours ago

When donating blood, plasma, human tissue or any other bodily sample for medical research, most people might not think about how it's being used. But if you were told, would you care?

Amgen tops Street 4Q forecasts

Jan 27, 2015

Amgen Inc. cruised to a 27 percent jump in fourth-quarter profit and beat Wall Street expectations, due to higher sales of nearly all its medicines, tight cost controls and a tax benefit.

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.